Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice

BACKGROUND: Breast cancer is one of the most deadly diseases in women. Inhibiting the synthesis of estrogen is effective in treating patients with estrogen-responsive breast cancer. Previous studies have demonstrated that use of cyclooxygenase (COX) inhibitors is associated with reduced breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Tsz Yan, Li, Fengjuan, Lin, Shu-mei, Chan, Franky L, Chen, Shiuan, Leung, Lai K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070644/
https://www.ncbi.nlm.nih.gov/pubmed/24923427
http://dx.doi.org/10.1186/1471-2407-14-426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070644/
https://www.ncbi.nlm.nih.gov/pubmed/24923427
http://dx.doi.org/10.1186/1471-2407-14-426

Ejemplares similares